Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Novartis AG published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 76
» View wsbtradio.com items only
    Apr 16, 2012 |Story| WSBT Radio
  1. Kanye West Sick of "Theraflu," Changes Song Title to "Way Too Cold"

    Maybe "Theraflu" just had way too many bad symptoms associated with it.
    Maybe "Theraflu" just had way too many bad symptoms associated with it. Kanye West has changed the title of his controversial new song following a backlash from the manufacturer of the drug it's named after, who slammed the rapper for inappropriately...

    Tags: People for the Ethical Treatment of Animals, Kim Kardashian, Music, Kanye West, Entertainment

  2. Jun 19, 2013 |Story| Reuters
  3. EU fines Lundbeck and others 146 million euros for blocking rival drugs

    Reuters
    BRUSSELS (Reuters) - European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of 146 million euros ($195 million) for blocking the supply of a cheaper anti-depressant to the market, the first EU sanction against such...

    Tags: Politics, Alpharma Incorporated, Chemical Industry, Pharmaceuticals, Deutsche Bank AG

  4. Jun 10, 2013 |Story| Reuters
  5. AstraZeneca pagará hasta 1.150 mln dlrs por Pearl

    Reuters
    Por Ben Hirschler LONDRES (Reuters) - AstraZeneca comprará al especialista estadounidense en medicamentos respiratorios Pearl Therapeutics por hasta 1.150 millones de dólares, en un nuevo paso de la segunda más grande farmacéutica de Gran Bretaña en...

    Tags: Seroquel (drug), AstraZeneca Plc, GlaxoSmithKline PLC

  6. Jun 10, 2013 |Story| Reuters
  7. Sanofi MS drug nears green light after pass-the-parcel marathon

    Reuters
    * European decision on Lemtrada expected this month * 25-year journey for drug passed from company to company * Scientists frustrated by delays, worried over pricing By Ben Hirschler LONDON, June 10 (Reuters) - One of the world's longest running...

    Tags: Pathology, Cambridge (England), Science and Technology, Drug Trafficking, GlaxoSmithKline PLC

  8. May 30, 2013 |Story| Reuters
  9. UK cost agency recommends Bayer, Regeneron eye drug

    Reuters
    LONDON, May 31 (Reuters) - Britain's healthcare cost watchdog NICE is recommending a new eye drug from Bayer and Regeneron, after a price discount was offered for its use on the state health service. The draft decision by the National Institute for...

    Tags: Macular Degeneration, United Kingdom, Germany

  10. May 29, 2013 |Story| Reuters
  11. Swiss take cue from EU members in corporate tax row

    Reuters
    * Tax breaks on foreign profits helped Swiss lure companies * EU wants Switzerland to abolish incentives * Looking to models used in other EU countries By Caroline Copley and Alice Baghdjian BERNE, May 29 (Reuters) - Switzerland is considering...

    Tags: Politics, Bern (Swiss Confederation), European Union, Finance, Economy, Business and Finance

  12. May 23, 2013 |Story| Reuters
  13. RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug

    Reuters
    By Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...

    Tags: Politics, Penicillin (drug), Chemical Industry, Science and Technology, MRSA

  14. May 22, 2013 |Story| Reuters
  15. Immune system cancer drugs tipped to be a $35 bln market

    Reuters
    * Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...

    Tags: Science and Technology, Bristol Myers Squibb Company, Health Treatments, GlaxoSmithKline PLC, Oncology

  16. May 22, 2013 |Story| Reuters
  17. Inmunoterapia contra el cáncer podría ser un mercado de 35.000 mln dlrs anuales

    Reuters
    Por Ben Hirschler LONDRES, 22 may (Reuters) - Una nueva ola de medicinas que emplea el poder del sistema inmunológico para luchar contra el cáncer podría convertirse en el mayor grupo de medicamentos de la historia, con ventas potenciales de 35.000...

    Tags: AstraZeneca Plc, Bristol Myers Squibb Company, Amgen Inc., Roche Holding AG, GlaxoSmithKline PLC

  18. Apr 12, 2013 |Story| Los Angeles Times
  19. Kareem Abdul-Jabbar continues to promote a healthy, active lifestyle

    Over the weekend, Hall of Fame center Kareem Abdul-Jabbar led a processional on a one-mile walk outside of the Georgia Dome in Atlanta. Abdul-Jabbar's Final Four Dome Dribble Fueled by Powerade was part of his campaign to encourage fun, healthy and...

    Tags: Kobe Bryant, Jimmy Kimmel, Leukemia, Kareem Abdul-Jabbar, Jimmy Kimmel Live! (tv program)

  20. Apr 1, 2013 |Story| Los Angeles Times
  21. Indian court ruling hailed as victory for generic drugs

    The Indian Supreme Court ruled Monday that a Swiss drug company cannot patent a medicine used to treat a rare form of leukemia, in a decision with global implications for generic drugs.
    The Indian Supreme Court ruled Monday that a Swiss drug company cannot patent a medicine used to treat a rare form of leukemia, in a decision with global implications for generic drugs. The court ruled that Glivec, the drug developed by Novartis, was...

    Tags: Leukemia, Drugs and Medicines, Contracts, India, Trade Dispute

  22. Mar 31, 2013 |Story| Los Angeles Times
  23. Drug maker Novartis loses India patent battle

    India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines.
    India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world will get continued access to cheap versions...

    Tags: Crime, Law and Justice, Leukemia, Chemical Industry, Pharmaceuticals, Science and Technology

 1  2 3 4 5 6 7Next >
Original site for Novartis AG topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Novartis AG Photos
Barbara Kittridge has been appointed chief marketing of...
(January 10, 2013)
Barbara Kittridge, chief marketing officer, Cardinal Path Inc.
Steve Auten has joined Cozen O'Connor as a member of th...
(September 5, 2012)
Steve Auten, partner, Cozen O'Connor
Since its release on Wednesday, April 4, West's single...
(April 8, 2012)
Kanye vs. Theraflu (2012)